
    
      This study is a prospective, randomized, controlled (randomized, parallel group, concealed
      allocation), double-blinded trial. All patients undergoing breast cancer operation will be
      randomized 1:1 to the treatment intervention with general anesthesia as an adjunct to
      Stellate-ganglion block with 0.25% ropivacaine hydrochloride or saline. The objective of the
      trial is to evaluate the postoperative sleep quality of patients undergoing breast cancer
      operation with Stellate-ganglion block 0.25% ropivacaine hydrochloride or saline.
    
  